Researchers Urge NIH/NEI Funding Increases as House and Senate Mark Up FY2016 NIH Funding Bills
Legislative Update
June 18, 2015
Prior to the June 17 markup of a Fiscal Year (FY) 2016 Labor, Health and Human Services, and Education (LHHS) appropriations bill by the House LHHS Appropriations Subcommittee and a similar markup by the companion Senate Subcommittee on June 23, the vision community urged Congress to fund the National Institutes of Health (NIH) at a level of at least $32 billion and the National Eye Institute (NEI) at $730 million as followed:
- NAEVR was pleased to hand-deliver to House and Senate appropriations leaders letters signed by the Association for Research and Vision in Ophthalmology (ARVO) Board of Trustees and the Association of University Professors of Ophthalmology (AUPO) department chairs from around the country that urged these NIH/NEI increases.
- ARVO members sent 1,500 letters to their Congressional delegations requesting support.
- NAEVRs educational foundation, the Alliance for Eye and Vision Research (AEVR) held a June 3 Congressional briefing that described NEI-funded research into inflammatory eye disease, specifically Uveitis.
The draft bill has provisions that address a number of specific diseases and initiatives, including:
- $866 million (a $300 million increase) for an Alzheimers research initiative
- $461 million (a $100 million increase) for the antibiotic resistance initiative
- $150 million (a $95 million increase) for the for the Brain Research through Application of Innovative Neurotechnologies (BRAIN) initiative; and
- the full $200 million requested by the administration for the Precision Medicine Initiative (PMI)
Numerous amendments to the Chairmans Mark were offered at the session—all by Subcommittee Democrats—and all were defeated by a show of hands along party lines. Each of the amendments would have increased spending on a particular section of the bill. Subcommittee Chairman Tom Cole (R-OK) noted that, because none had an offset reducing spending by a corresponding amount and therefore would put the bill over the Subcommittees allocation, he voted with his Republican colleagues against them all, even those he stated that he thought had merit.
Subcommittee Ranking Member Rosa DeLauro (D-CT) offered an amendment that would have increased funding for the NIH by $3 billion, to $34.2 billion, adjusting the Budget Control Act cap to allow for the additional spending, but the amendment was rejected. Earlier, she had offered an amendment raising all spending levels in the bill to the amounts in President Obamas proposed budget, which was also rejected.
Another amendment, offered by Rep. Lucille Roybal-Allard (D-CA), would have restored funding to the Agency for Healthcare Research and Quality (AHRQ), which had all of its funding eliminated in the draft legislation. AHRQ conducts analyses on the efficacy of different treatments for diseases, but Republicans believe that it leads to government selection of winners and losers in the healthcare delivery system and have sought to eliminate it for a number of years.
Other amendments that were offered, and rejected, addressed funding levels for early childhood programs, family planning, school funding, and job training.
At the end of the markup, Rep. DeLauro offered three amendments en bloc, due to time constraints. One of the amendments would have restored funding for the Affordable Care Act (ACA). As with all other amendments, it was rejected by a show of hands.
After all amendments were considered, the bill was approved, also by a show of hands.
The full House Appropriations Committee is expected to take up the bill the week of June 22, and Members of both parties have indicated that the fight over the spending levels in the legislation will likely be addressed at the session. On the other side of Capitol Hill, the companion Senate LHHS Appropriations Subcommittee is also expected to mark up its bill on June 23, with full Senate Appropriations Committee action on June 25.